Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Disclosure statements are available on the authors' profiles:
Hypogammaglobulinemia secondary to B-cell depleting therapies in neuroimmunology: Comparing management strategiesMult Scler J Exp Transl Clin 2023 Jul 01;9(2)20552173231182534, H Kelly, A Vishnevetsky, LB Chibnik, M Levy
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.